JTCS Medtronic Endurant
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Leval, M. R.
Right arrow Articles by Higenbottam, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Leval, M. R.
Right arrow Articles by Higenbottam, T.

The Journal of Thoracic and Cardiovascular Surgery, Vol 101, 633-641, Copyright © 1991 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Heart and lung transplantation for terminal cystic fibrosis. A 4 1/2- year experience

MR de Leval, R Smyth, B Whitehead, JP Scott, MJ Elliott, L Sharples, N Caine, P Helms, IR Martin and T Higenbottam
Hospital for Sick Children, Cambridge, England.

From among 112 patients with cystic fibrosis who were assessed for heart-lung transplantation, 83 were accepted. Twenty-six died while awaiting heart-lung transplantation and 32 had the operation. The management and the outcome of these 32 patients is reported. Survival, infection, and rejection rates among these patients were compared with those of 61 patients without cystic fibrosis who underwent heart-lung transplantation between 1984 and 1990. The cumulative survival rate was 72.29% +/- 94.91% at 1 year and 55.59% +/- 7.50% at 3 years. The mortality rate was slightly higher in the group with cystic fibrosis during the first year after the operation but it was lower at 3 years. The difference, however, could have been due to chance alone (p = 0.308). The same was true for the prevalence of rejection (up to 6 months: chi 2 = 1.8141, p = 0.17), and infection (up to 6 months: chi 2 = 2.20, p = 0.14), between the two groups. It is concluded that cystic fibrosis does not constitute an additional risk in terms of survival and morbidity after heart-lung transplantation.


This article has been cited by other articles:


Home page
Eur Respir JHome page
J. S. Ganesh, C. A. Rogers, R. S. Bonser, N. R. Banner, and on behalf of the steering group of the UK Cardioth
Outcome of heart-lung and bilateral sequential lung transplantation for cystic fibrosis: a UK national study
Eur. Respir. J., June 1, 2005; 25(6): 964 - 969.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
T. M. Egan, F. C. Detterbeck, M. R. Mill, M. S. Bleiweis, R. Aris, L. Paradowski, G. Retsch-Bogart, and B. S. Mueller
Long term results of lung transplantation for cystic fibrosis
Eur J Cardiothorac Surg, October 1, 2002; 22(4): 602 - 609.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
M. Murtra
The adventure of cardiac surgery
Eur J Cardiothorac Surg, February 1, 2002; 21(2): 167 - 180.
[Full Text] [PDF]


Home page
Clinical Infectious DiseasesHome page
R. Speich and W. van der Bij
Epidemiology and Management of Infections after Lung Transplantation
Clinical Infectious Diseases, July 1, 2001; 33(Supplement_1): S58 - S65.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. CHAPARRO, J. MAURER, C. GUTIERREZ, M. KRAJDEN, C. CHAN, T. WINTON, S. KESHAVJEE, M. SCAVUZZO, E. TULLIS, M. HUTCHEON, et al.
Infection with Burkholderia cepacia in Cystic Fibrosis . Outcome Following Lung Transplantation
Am. J. Respir. Crit. Care Med., January 1, 2001; 163(1): 43 - 48.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. W. Barlow, R. C. Robbins, M. R. Moon, O. Akindipe, J. Theodore, and B. A. Reitz
HEART-LUNG VERSUS DOUBLE-LUNG TRANSPLANTATION FOR SUPPURATIVE LUNG DISEASE
J. Thorac. Cardiovasc. Surg., March 1, 2000; 119(3): 466 - 476.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
D. Metras, L. Viard, B. Kreitmann, A. Riberi, A. Pannetier-Mille, O. Garbi, J.-Y. Marti, and P. Geigle
Lung infections in pediatric lung transplantation: experience in 49 cases
Eur J Cardiothorac Surg, April 1, 1999; 15(4): 490 - 495.
[Abstract] [Full Text] [PDF]


Home page
CLIN PEDIATRHome page
C. G. Caronia, J. Gorvoy, P. Silver, C. Quinn, L. Nimkoff, and M. Sagy
Use of Bilevel Positive Airway Pressure (BIPAP) in End-Stage Patients with Cystic Fibrosis Awaiting Lung Transplantation
Clinical Pediatrics, September 1, 1998; 37(9): 555 - 559.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. M. Egan, F. C. Detterbeck, M. R. Mill, K. K. Gott, J. B. Rea, J. McSweeney, R. M. Aris, and L. J. Paradowski
Lung transplantation for cystic fibrosis: effective and durable therapy in a high-risk group
Ann. Thorac. Surg., August 1, 1998; 66(2): 337 - 346.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. A. Piotrowski, F. H. Splittgerber, T. J. Donovan, F. Ratjen, and H.-R. Zerkowski
Single-Lung Transplantation in a Patient With Cystic Fibrosis and an Asymmetric Thorax
Ann. Thorac. Surg., November 1, 1997; 64(5): 1456 - 1458.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. P. A. Couetil, D. P. Houssin, O. Soubrane, P. G. Chevalier, B. E. Dousset, D. Loulmet, A. Achkar, M. J. Tolan, C. I. Amrein, A. Guinvarch, et al.
COMBINED LUNG AND LIVER TRANSPLANTATION IN PATIENTS WITH CYSTIC FIBROSIS: A 4 1/2-year experience
J. Thorac. Cardiovasc. Surg., November 1, 1995; 110(5): 1415 - 1423.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. M. Egan, F. C. Detterbeck, M. R. Mill, L. J. Paradowski, R. P. Lackner, W. D. Ogden, J. R. Yankaskas, J. H. Westerman, J. T. Thompson, M. A. Weiner, et al.
Improved results of lung transplantation for patients with cystic fibrosis
J. Thorac. Cardiovasc. Surg., February 1, 1995; 109(2): 224 - 235.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
H. Shennib and G. Massard
Airway complications in lung transplantation
Ann. Thorac. Surg., February 1, 1994; 57(2): 506 - 511.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. Massard, H. Shennib, D. Metras, J. Camboulives, L. Viard, D. S. Mulder, C. I. Tchervenkov, J.-F. Morin, R. Giudicelli, and M. Noirclerc
Double-lung transplantation in mechanically ventilated patients with cystic fibrosis
Ann. Thorac. Surg., May 1, 1993; 55(5): 1087 - 1092.
[Abstract] [PDF]


Home page
JAMAHome page
Diagnostic and Therapeutic Technology Assessment (DATTA)
JAMA, February 17, 1993; 269(7): 931 - 936.
[PDF]


Home page
Ann. Thorac. Surg.Home page
D. Metras, H. Shennib, B. Kreitmann, J. Camboulives, L. Viard, M. Carcassonne, R. Giudicelli, M. Noirclerc, and The Joint Marseille-Montreal Lung Transplant Progr
Double-lung transplantation in children: A report of 20 cases
Ann. Thorac. Surg., February 1, 1993; 55(2): 352 - 357.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. M. Egan, J. H. Westerman, C. J. Lambert, F. C. Detterbeck, J. T. Thompson, M. R. Mill, B. A. Keagy, L. J. Paradowski, and B. R. Wilcox
Isolated lung transplantation for end-stage lung disease: A viable therapy
Ann. Thorac. Surg., April 1, 1992; 53(4): 590 - 596.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1991 by The American Association for Thoracic Surgery.